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Abstract To date, little is known about enduring clinical
distress as measured with the commonly used distress
thermometer. We therefore used the distress thermometer
to examine: (a) the prevalence of enduring clinical distress,
distress-related problems, and subsequent wish for referral
of women with breast cancer, and (b) sociodemographic,
clinical, and psychosocial predictors of enduring clinical
distress. The study had a multicenter, prospective, obser-
vational design. Patients with primary breast cancer com-
pleted a questionnaire at 6 and 15 months postdiagnosis.
Medical data were retrieved from chart reviews. Enduring
clinical distress was defined as heightened distress levels
over time. The prevalence of enduring clinical distress,
problems, and wish for referral was examined with
descriptive analyses. Associations between predictors and
enduring clinical distress were examined with multivariate
analyses. One hundred sixty-four of 746 patients (22 %)
reported having enduring clinical distress at 6 and
15 months postdiagnosis. Of these, 10 % wanted to be
referred for care. Fatigue was the most frequently reported
problem by patients with and without clinical distress, at
both time points. Lack of muscle strength (OR = 1.82,
95 % CI 1.12–2.98), experience of a low level of life sat-
isfaction (OR = 0.77, 95 % CI 0.67–0.89), more frequent
cancer worry (OR = 1.40, 95 % CI 1.05–1.89), and neu-
roticism (OR = 1.09, 95 % CI 1.00–1.18) were predictors
of enduring clinical distress. In conclusion, one in five
women with breast cancer develops enduring clinical dis-
tress. Oncologists, nurse practitioners, and cancer nurses
are advised to use single-item questions about distress and
distress-related problems to ensure timely detection of
high-risk patients. Providers should also routinely assess
fatigue and its causes, as fatigue is the most frequently
reported distress-related problem over time.
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Introduction
Coping with breast cancer, its treatment, and consequences
can be stressful and, if not successful, can result in clini-
cally relevant levels of psychological distress. Twenty-five
to fifty percent of all cancer patients experience clinically
relevant distress, which has been associated with lower
treatment adherence, poorer clinical and psychosocial
outcomes, and less satisfaction with medical care [1–6].
Breast cancer patients’ distress levels may rise at different
stages throughout the disease trajectory [7–11]. For
example, some patients experience clinical distress just
postdiagnosis, while others are mostly affected after
treatment due to the discontinuation of regular contacts
with medical specialists and/or to treatment-induced side
effects [12, 13]. Fortunately, for most patients, distress
levels tend to return to subclinical levels with time
[7, 8, 10, 11, 14, 15]. However, a subgroup of patients
develops enduring, heightened, distress. Enduring clinical
distress within 8 months after surgery predicts poorer
psychosocial outcomes 6 years later [6]. Thus, clinicians
and cancer nurses ought to be especially watchful of
patients at risk for developing enduring distress.
In order to ensure timely detection, discussion, and
treatment of distress, the National Comprehensive Cancer
Center recommends use of an ultrashort screening tool, the
Distress Thermometer, and accompanying Problem List
[16]. This self-report questionnaire assesses cancer
patients’ distress level and distress-related problems, along
with their wish for referral to professional care. The Dis-
tress Thermometer is currently used in various countries
worldwide, including the United States, the United King-
dom, Japan, and China (see [17] for an overview). Given its
common use, many oncologists and cancer nurses would
benefit from knowing how many and which women with
breast cancer are most likely to develop enduring clinical
distress as measured with the Distress Thermometer.
However, while a number of cross-sectional studies used
the screening tool to examine distress among women with
breast cancer [18–29], only one examined continuing dis-
tress, during the treatment phase [10]. Thus, more longi-
tudinal research is needed.
In the present study we aimed to extend current insights
using the Distress Thermometer to investigate which
women are most likely to experience enduring distress after
treatment for breast cancer. More specifically, enduring
distress was defined as elevated distress levels at two points
in time: 6 months postdiagnosis, around the completion of
adjuvant therapy, and 9 months later, when women, gen-
erally, have reached the early survivorship phase [8]. We
investigated the prevalence of enduring clinical distress,
the prevalence of women’s wish for referral, and
sociodemographic, clinical, and psychosocial predictors of
enduring clinical distress.
Methods
Participants and design
This study had a prospective, multicenter, observational
design. Women with primary breast cancer who had been
diagnosed up to 6 months earlier in one of nine hospitals in
the Netherlands (i.e., six academic hospitals, two commu-
nity hospitals, and one comprehensive cancer center) were
eligible for the study, regardless of type of treatment.
Patients were excluded if they were younger than 18 years,
not literate in Dutch, or had a prognosis of 3 months or
less. To minimize patient burden, participating centers
could also exclude patients who were already participating
in a concurrent study. Inclusion took place between March
2011 and 2013.
Participants completed a self-report questionnaire at two
points in time: 6 months (time window 5–7 months) and
15 months (time window 14–16 months) postdiagnosis.
Medical data were retrieved via chart reviews. Because the
study was observational in nature, following Dutch regu-
lations and guidelines regarding ethics review, it did not
require formal review by the institutional review boards of
the participating centers.
Procedure
Eligible patients with breast cancer were identified by their
oncologist, nurse practitioner, or cancer nurse during a
hospital visit. The health care provider informed the patient
about the study and asked whether she would consider
participation. The investigator subsequently invited inter-
ested patients to participate by e-mail or telephone. Par-
ticipants could choose between a web-based questionnaire
accessible through e-mail or a paper questionnaire sent by
regular mail with a stamped return envelope. Formal
agreement to participation involved signing an informed
consent form. If necessary, patients received reminders
after 2 and 4 weeks by e-mail or telephone.
Outcome measures
Psychosocial distress, distress-related problems, and wish
for referral were assessed at both assessment points with
the validated Dutch version of the Distress Thermometer,
accompanied by the Problem List [16, 30, 31]. The Ther-
mometer measures the level of distress in the past week
with a single item (score 0–10). In the introduction to the
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questionnaire, we emphasized that it was a measure of
distress related to breast cancer and its treatment. Based on
the Dutch validation study [30] (see also [31]), a score of
C5 was used to identify women with clinically relevant
levels of distress.
The Dutch version of the Problem List identifies 47
problems across the practical, family/social, emotional,
religious/spiritual, and physical domains (response cate-
gories for the presence of each problem: yes/no). Wish for
referral is assessed with one question. Patients are asked
whether they would like to talk with a professional about
their problems (response categories yes/maybe/no). In the
current study, the response category ‘not applicable’ was
added for patients who did not report any problems. We
recoded the response categories to ‘yes or maybe’ versus
‘no or not applicable’ to enable comparability with other
studies.
Sociodemographic predictors
Age at diagnosis, nationality, educational level, living sit-
uation, and employment status were assessed by self-report
6 months postdiagnosis.
Clinical predictors
Type of breast cancer, cancer stage (via pTNM-classifica-
tion), types of treatments, and presence of recurrence (yes/
no) were retrieved from medical chart reviews. Previous
use of psychosocial services (yes/no) and number of
comorbid conditions (adapted from [32]) were assessed by
self-report 6 months postdiagnosis.
Psychosocial predictors
We decided a priori to include the three most prevalent
distress-related problems reported at 6 months postdiag-
nosis, as assessed with the previously described Problem
List, as psychosocial predictors. In addition, social support,
cancer worry, present life satisfaction, and neuroticism, as
measured 6 months postdiagnosis, were included (variables
selected on the basis of [8, 33–39]).
Social support was measured with the emotional/infor-
mational support subscale of the Medical Outcomes Study
Social Support Survey (8 items, range 1 ‘support not
available’ to 5 ‘support always available’, a = .96 based
on data from this study) [40, 41].
Life satisfaction was measured with a single item that
asked patients about their present satisfaction with life as a
whole (range 0–10) [42].
Frequency of cancer worry was assessed with a single
item (range 1 ‘never’ to 4 ‘always’) (adapted from [43]).
Neuroticism was measured with a subscale of the
Eysenck Personality Questionnaire (12 y/n items) [44, 45].
Data analyses
Prior to the main analyses, we first examined missing data
patterns with separate variance t-tests, cross tabulations, a
tabulated pattern table and Little’s missing completely at
random test with a v2 statistic (p\ 0.05). The results did not
indicate substantial influence of the missing data on the
results. Thus, we assumed that these data were missing at
random. The percentage of missing values for all the vari-
ables ranged from 0 % to 8 %. The data were subsequently
multiple imputed by fully conditional specification with a
maximum of five iterations [46, 47]. Secondly, we examined
the correlations between distress and the psychosocial
measures at 6 months postdiagnosis with Spearman’s rank
correlation coefficients [48] to ascertain the degree of
interdependence. The correlations ranged from-0.15 for the
correlation with social support to -0.52 for the correlation
with life satisfaction, indicating low to moderate associa-
tions. We then proceeded to the main analyses.
The prevalence of enduring clinical distress, distress-re-
lated problems, and a wish for referral was examined with
descriptive analyses. Associations between predictors and
enduring clinical distress were investigated twice. We first
performed univariate logistical regression analyses (signifi-
cance level p\ 0.10), followed by a multivariate analysis
with the predictors that were found to be significant in the
univariate analyses (significance level for the multivariate
analysis p\ 0.05).We then examined the associations again
with Generalized Estimating Equations, taking into account
the within-subject correlations. The same predictors were
found to be significant in the multivariate analysis, with
comparable parameters and standard errors. Therefore, only
the results of the logistical regression analyses are reported,
in odds ratios (OR). All of the analyses were conducted with
SPSS version 21 for Windows.
Results
Sample
In total, 1353 women with breast cancer were assessed for
study eligibility. Of these women, 1263 were eligible, and
1012 agreed to participate (80.1 % of the eligible women).
The current analyses were restricted to the 746 women who
completed both the first and second questionnaires at 6 and
15 months postdiagnosis (73.7 % of the participants) (see
Fig. 1). Themajority of thewomenwas diagnosedwith stage
1 or 2 invasive breast cancer, and was treated with lumpec-
tomy and radiotherapy. Over 60 % had one or more
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comorbid conditions (Table 1). Of the participants, 45.7 %
chose to receive a paper rather than a web-based
questionnaire.
Participants did not differ significantly in age (groups
based on median split, p[ 0.10) or cancer stage from
nonrespondents, i.e., women who were approached by the
researcher but who could not be reached, declined to par-
ticipate, or who did not return both questionnaires (v2,
p[ 0.10). Furthermore, respondents who only completed
the questionnaire at 6 months postdiagnosis (n = 111) did
not differ significantly in age (v2, p[ 0.10), cancer stage
(v2, p[ 0.10), or distress scores (t-tests, p[ 0.10) from
the respondents who completed the questionnaires at both 6
and 15 months postdiagnosis (n = 746). We did not collect
background data from patients who did not want to be
approached about the study (n = 74).
Prevalence of enduring clinical distress, distress-
related problems, and wish for referral
Forty-one percent of the patients experienced clinical dis-
tress 6 months postdiagnosis, and 32 % 15 months post-
diagnosis. Twenty-two percent of the patients experienced
enduring clinical distress at 6 and 15 months postdiagnosis
(Table 2; Fig. 2). The most frequently reported problems
6 months postdiagnosis were fatigue, lack of physical fit-
ness, lack of muscle strength, sleep problems, and con-
centration problems for both clinically and nonclinically
Assessed for eligibility in hospital (n=1353)
T1 Questionnaire returned (n=857)
Declined to participate (n=138)
Participants (n=1012)
T2 Questionnaire returned (n=746)
Excluded:
Not meeting inclusion criteria (n=13)
Not meeting inclusion period (n=77)
Eligible (n=1263)
Reached (n=1150)
Not reached (n=39)
Declined to be approached by
a researcher about this study (n=74)
Approached by researcher to participate 
(n=1189)
T1 not returned (n=151)
Lost contact (3)
Deceased (1)
T2 not returned (n=94)
Lost contact (14)
Deceased (3)
Fig. 1 Flowchart
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distressed patients. Fifteen months postdiagnosis fatigue,
lack of physical fitness, and sleep problems were still most
frequently reported (Table 3). Ten percent of the patients
with enduring clinical distress had a wish for referral
15 months postdiagnosis. In addition, 17 % of patients
without enduring clinical distress also had a wish for
referral (Table 4).
Predictors of enduring clinical distress
Of the sociodemographic factors, younger age (OR = 0.96),
living with a partner and children (OR = 1.75) or only with
children (OR = 2.57), and having a paid job compared to
being retired (OR = 0.43) predicted enduring clinical dis-
tress in the univariate analyses (p\ 0.10). Furthermore,
having a mastectomy compared to a lumpectomy
(OR = 1.72), having chemotherapy (OR = 2.47) or radio-
and chemotherapy (OR = 1.85) compared to radiotherapy
only, having received psychosocial services before the breast
cancer diagnosis (OR = 2.03), and having two or more
comorbid conditions (OR = 1.51) were significant clinical
predictors of enduring clinical distress in these analyses.
Additionally, all the seven psychosocial factors, namely
fatigue (OR = 4.81), lacking physical fitness (OR = 3.12),
lacking muscle strength (OR = 4.16), experiencing a low
level of social support (OR = 0.75), a low level of life sat-
isfaction (OR = 0.60), more frequent cancer worry
(OR = 2.23), and more neuroticism (OR = 1.23) were
identified as univariate significant predictors of enduring
clinical distress.
In the multivariate analysis lacking muscle strength
(OR = 1.82, 95 % CI 1.12–2.98), experience of a low
level of life satisfaction (OR = 0.77, 95 % CI 0.67–0.89),
more frequent cancer worry (OR = 1.40, 95 % CI
1.05–1.89), and neuroticism (OR = 1.09, 95 % CI
1.00–1.18) remained significant (Table 5). The variance
explained (R2 Nagelkerke [49]) across imputed datasets
was, on average, 30 %.
Table 1 Sample Characteristics (n = 746)
Characteristics Total sample
Sociodemographic factors
Age at diagnosis (median, range) 58 (24–83)
Nationality (n, %)
Dutch only 716 (96.0)
Dutch and other or other only 30 (4.0)
Educational level (n, %)a
Low 346 (46.4)
Intermediate 185 (24.8)
High 215 (28.8)
Living situation (n, %)
With partner 383 (51.3)
With partner and child(ren) 192 (25.7)
With child(ren) 34 (4.6)
Alone 127 (17.0)
Other 10 (1.3)
Employment status (n, %)
Paid work 278 (37.3)
Homemaker 141 (18.9)
Retired 197 (26.4)
No work or unpaid 56 (7.5)
(Partly) Work-disabled due to breast cancer 74 (9.9)
Clinical factors
Type of breast cancer (n, %)
Ductal carcinoma in situ (DCIS) 104 (13.9)
Invasive and DCIS 57 (7.6)
Invasive 585 (78.4)
Cancer stage at diagnosis (n, %)
TIS: carcinoma in situ 104 (13.9)
Invasive early stage (T1/T2) 621 (83.2)
Invasive late stage (T3/T4) 21 (2.8)
Type of surgery (n, %)
Lumpectomy 630 (84.5)
Mastectomy 105 (14.1)
Lumpectomy and mastectomy 9 (1.2)
No lumpectomy or mastectomy 2 (0.3)
Radio- and/or chemotherapy (n, %)
Radiotherapy only 470 (63.0)
Chemotherapy only 24 (3.2)
Radio- and chemotherapy 198 (26.5)
No radio- or chemotherapy 54 (7.2)
Other types of treatment (n, %; yes/no)
Hormonal 258 (34.6)
Immunotherapy 32 (4.3)
Recurrence (n, %)
No 731 (98.0)
Yes 15 (2.0)
Previous use of psychosocial services (n, %)
No 578 (77.5)
Table 1 continued
Characteristics Total sample
Yes 168 (22.5)
Comorbidity (n, %)
0 comorbid conditions 282 (37.8)
1 comorbid condition 231 (31.0)
2 or more comorbid conditions 233 (31.2)
Psychosocial factors 6 months postdiagnosis
Social support (median, range) 4.25 (1–5)
Life satisfaction (median, range) 7 (0–10)
Cancer worry (median, range) 3 (1–4)
Neuroticism (median, range) 2 (0–12)
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Discussion
While a number of studies have examined distress among
women with breast cancer, insight into enduring distress,
and predictors of enduring distress is still scarce, especially
with regard to enduring distress as measured with the
Distress Thermometer. In this longitudinal, nationwide,
study we established that one in five patients with breast
cancer reported clinical distress at 6 and 15 months post-
diagnosis, as measured with the Distress Thermometer.
Fatigue and lack of physical fitness were the most fre-
quently reported problems at both time points. Ten percent
of the participants with enduring clinical distress had a
wish for referral.
The prevalence of distress in the only other, Danish,
study that examined persistent distress with the Distress
Table 2 Prevalence of enduring clinical distress (score C5 at both time points)
Distress 15 months postdiagnosis (n, %) Total
Score\5 Score C5
Distress 6 months postdiagnosis (n, %) Score\5 367 (49.2) 74 (9.9) 441 (59.1)
Score C5 142 (19.0) 163 (21.8) 305 (40.9)
Total 509 (68.2) 237 (31.7) 746 (100.0)
Fig. 2 Prevalence of distress 6 and 15 months postdiagnosis
(n = 746)
Table 3 Top 10 distress-related problems 6 and 15 months postdiagnosis
Rank 6 months postdiagnosis 15 months postdiagnosis
Distress score\5 (%) Distress score C5 (%) Distress score\5 (%) Distress score C5 (%)
1 Fatigue (33.2) Fatigue (35.3) Fatigue (28.3) Fatigue (24.6)
2 Lack of physical fitness (27.7) Lack of physical fitness (33.5) Lack of physical fitness (23.6) Lack of physical fitness (22.3)
3 Lack of muscle
strength
(18.6) Lack of muscle
strength
(26.7) Sleep problems (21.1) Sleep problems (19.7)
4 Sleep problems (18.3) Sleep problems (24.8) Memory problems (18.2) Concentration
problems
(18.8)
5 Concentration
problems
(17.4) Concentration
problems
(23.9) Concentration
problems
(17.7) Memory problems (18.4)
6 Emotional control (16.1) Housekeeping (22.3) Lack of muscle
strength
(16.6) Lack of muscle
strength
(18.4)
7 Memory problems (15.7) Emotional control (22.2) Tingling in hands/feet (14.9) Emotional control (18.2)
8 Tension/nervousness (15.2) Tension/nervousness (22.0) Weight change (14.8) Tension/nervousness (18.0)
9 Skin dry/itchy (14.2) Pain (21.1) Emotional control (14.5) Pain (16.5)
10 Weight change (13.4) Daily activities (19.6) Tension/nervousness (13.8) Fears (15.4)
Table 4 Prevalence of wish for
referral
Wish for referral 15 months postdiagnosis (n, %) Total
No Yes or maybe
Enduring clinical distress (n, %) No 456 (61.1) 127 (17.0) 583 (78.2)
Yes 89 (11.9) 74 (9.9) 163 (21.8)
Total 545 (73.1) 201 (26.9) 746 (100.0)
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Thermometer was only 8 % within the first 8 months
postdiagnosis (n = 323) [10]. The lower prevalence in that
study can be explained by the higher cut-off point of seven
used. We found a comparable percentage (7 %) when we
applied a cut-off point of seven to our data to enable
comparison. The choice of a validated cut-off score
depends on the purpose of screening [50], and this may
differ between countries. In general, a higher score implies
higher sensitivity but also a higher percentage of false
negatives.
A remarkable finding was that the percentage of patients
with a wish for referral in the group with enduring clinical
distress was lower than in the group without enduring
clinical distress (10 vs. 17 %). This is in contrast with the
findings of previous, cross-sectional, studies that examined
distress. The wish for a referral in these studies was, gen-
erally, more prevalent among women with a clinical level
of distress than in women without distress (e.g., [21]). Our
finding might indicate that a portion of the patients with
enduring clinical distress has already been identified and
referred through effective screening. Unfortunately, we did
not assess use of psychosocial services up to 15 months,
which would allow testing of this hypothesis.
Depending on service availability, all wishes for a
referral deserve further inquiry. The high percentage of
patients with enduring clinical distress without a wish for
referral raises the question if and how a practitioner should
proceed in that situation. Minimally, we would recommend
that providers inform patients about the health risks asso-
ciated with enduring clinical distress [6], and about those
services that are available to manage and hopefully resolve
such distress. Providers should also explore the patients’
reason for their response. Some patients may already
receive professional support or may prefer to deal with
their distress on their own, perhaps with help from their
informal network [51–54]. In the end, the wish to accept a
referral is up to the patients. However, there may also be
patients who misperceive their distress as not severe
enough to ask for help, and who might accept help after
being otherwise informed [53].
While younger age, having a partner, having less edu-
cation, and having chemotherapy and not radiotherapy,
were previously found to be associated with enduring
clinical distress [10], none of these factors were significant
predictors in our multivariate model. Based on our results,
psychosocial variables appear more relevant than clinical
variables to identify patients at risk of developing enduring
clinical distress. Our analyses identified lack of muscle
strength, a low level of life satisfaction, and more frequent
cancer worry as significant predictors, independent of one’s
level of neuroticism (see also [6, 52]). To our knowledge,
this study is the first to demonstrate that these factors are of
value in predicting enduring clinical distress of women
Table 5 Predictors of enduring clinical distress
Predictora Multivariate analysis
OR (95 % CI)b, c
Sociodemographic factors
Age at diagnosis 0.99 (0.96–1.03)
Living situation
With partner 1.00 (reference)
With partner and child(ren) 1.33 (0.72–2.43)
With child(dren) 2.38 (0.95–5.95)
Alone 1.09 (0.58–2.04)
Other 2.58 (0.44–15.24)
Employment status
Paid work 1.00 (reference)
Homemaker 0.73 (0.39–1.38)
Retired 0.72 (0.33–1.57)
No work or unpaid 1.19 (0.47–3.04)
(Partly) Work-disabled due to breast cancer 0.69 (0.31–1.55)
Clinical factors
Type of surgeryd
Lumpectomy 1.00 (reference)
Mastectomy 1.12 (0.54–2.30)
Lumpectomy and mastectomy 1.08 (0.15–7.67)
Radio- and or chemotherapy
Radiotherapy only 1.00 (reference)
Chemotherapy only 1.04 (0.29–3.76)
Radio- and chemotherapy 1.25 (0.76–2.05)
No radio- or chemotherapy 1.58 (0.61–4.12)
Previous use of psychosocial services
No 1.00 (reference)
Yes 1.19 (0.74–1.92)
Comorbidity
0 comorbid conditions 1.00 (reference)
1 comorbid condition 1.19 (0.71–2.02)
2 or more comorbid conditions 1.69 (0.98–2.93)
Psychosocial factors
Fatigue
No 1.00 (reference)
Yes 1.31 (0.67–2.56)
Lack of physical fitness
No 1.00 (reference)
Yes 1.75 (0.90–3.38)
Lack of muscle strength
No 1.00 (reference)
Yes 1.82 (1.12–2.98)
Social support 0.96 (0.77–1.19)
Life satisfaction 0.77 (0.67–0.89)
Cancer worry 1.40 (1.05–1.89)
Neuroticism 1.09 (1.00–1.18)
a Predictors are measured at 6 months postdiagnosis. Women with
enduring distress are compared to those without enduring distress
b OR = odds ratio; CI = confidence interval
c Printed in bold: multivariate analysis p\ 0.05
d Patients who did not receive surgery (n = 2) were excluded from
the analyses
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with breast cancer. Based on our and previous findings,
addition of cancer worry to future versions of the Problem
List warrants further research attention (e.g., [55]; see also
[37]).
Life satisfaction or happiness is increasingly recognized
as a vital contributor to health, (partly) independent of
negative affect (e.g., [56, 57]). It may be important to
consider during the development of interventions to
diminish distress. Some patients may prefer such a positive
approach. A recent study demonstrated that the level of
happiness experienced by breast cancer patients can, to a
certain degree, be enhanced through intervention [35].
A study limitation is that we were not able to gather
information about patients who declined to be approached
for the study. Therefore, we could not establish our sam-
ple’s representativeness in that regard. We did establish
that there was no indication of a sample bias resulting from
loss to follow-up. Another limitation is the large proportion
of participants recruited at radiotherapy departments. As a
consequence, patients with breast cancer who do not
receive radiotherapy, though a minority, were underrepre-
sented in our sample. To give an impression, a previous
study based on data from a Dutch population-based,
regional cancer registry, indicated that 17 % of the women
with breast cancer received systemic therapy without
radiotherapy in the period 2002–2006 [58]. Finally, our
study design did not allow us to make a distinction between
women with breast cancer who experienced clinical dis-
tress continuously or intermittently, i.e., at the two
assessment points only.
Strengths of the study are its large sample size, the
prospective design, and the inclusion of psychosocial pre-
dictors that are easy to assess in clinical practice. We were
able to use the Distress Thermometer to address two
research topics that were recently identified as relevant in
an ongoing debate about the usefulness and validity of
screening for distress [59]. First, we investigated the
occurrence of enduring clinical distress within a relevant
time period [7, 11]. Second, we identified possible modi-
fiable predictors of enduring clinical distress as targets for
future interventions. While some of these predictors were
previously found to be associated with distress, their
importance in relation to predicting enduring distress had
yet to be established. Furthermore, our study is the first to
examine how many women with enduring distress would
like a wish for a referral to professional care.
We recommend further studies of modifiable psy-
chosocial factors in relation to resilience to distress over
time in order to determine whether the occurrence of dis-
tress may be prevented even before its first manifestation
[7, 8, 14]. We further suggest that patients’ need for help in
relation to distress be assessed more comprehensively than
with the single question about a wish for referral. A
substantial percentage of the patients who do not wish to
talk to a professional, may consider use of other support
services such as participating in an e-health intervention or
support group. Finally, a large percentage of variance in
our multivariate model remained unexplained. We recom-
mend investigation of the influence of treatment center
variables such as patient volume and waiting time before
surgery as relevant predictors of breast cancer patients’
distress, in addition to patient-based predictors. Treatment
center variables might be important predictors of psy-
chosocial outcomes [60].
In conclusion, one in five women with breast cancer
experiences enduring clinical distress after treatment. In
order to ensure timely detection of patients with enduring
clinical distress, oncologists and cancer nurses are advised
to pay special attention to distressed patients with a lack of
muscle strength, as measured by the Distress Thermometer
and Problem List. Fatigue is the most frequently reported
problem over time, and thus should be routinely assessed
and adequately addressed. Developers of distress inter-
ventions are advised to target these problems as well as life
satisfaction and cancer worry in their program.
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